Newly Released Agenda for Biosimilars Europe 2016 to Feature Talks from Merck, Boehringer Ingelheim and Bristows LLC
SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe, taking place on 29th & 30th September 2016 in Central London, UK.
London, United Kingdom, May 09, 2016 --(PR.com)-- Registration is now live to attend Biosimilars Europe set to take place this autumn in London, UK.
Widely recognized as one of the most profitable areas of drug development, the global biosimilars market is expected to grow at a CAGR of 40.3% by 2020.* With a raising demand for cost effective biosimilar drugs, Biosimilars Europe 2016 returns for its 7th annual show to showcase the latest updates in regulation, patent expiries and tactical approaches to market entry through informed guidance delivered by a top panel of speakers such as Merck Group, Boehringer Ingelheim GmbH, Bristows LLC and medical agencies from across Europe.
Agenda Highlights Include:
* Insight into future projections presented in an opening keynote by industry specialist, Dr Duncan Emerton, FirstWord.
* 1st hand experience on strategy and portfolio management in a VUCA (Volatile, Uncertain, Complex & Ambiguous) world through a case study on emerging biosimilars, presented by Merck Group.
* Case study updates into both USA and UK litigation with Bristows LLP.
* Guidance into entering emerging markets with insight into current guidelines, regulation, and pricing & reimbursement strategies, from Shanghai CP Guojian Pharmaceuticals.
* A spotlight session on commercialisation featuring talks from RJW & Partners and Abzena.
* A spotlight session on cutting edge technological developments with progressive outlook into bioanalytical analysis, yielding 3D structure of monoclonal antibodies, and opportunities for biosimilars in medical device components.
The Notable Speaker Line-Up Will Include:
• Huiguo Hu, General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co Ltd
• Dr Niraj Chhaya, Risk Management, Boehringer Ingelheim GmbH
• Atanas Dimitrov, Head of Strategy & Portfolio Management, Merck Group
• Dr Alok Sharma, Head, Bio-Analytical Development, Lupin Ltd
• Dr Andrea Laslop, Head of Scientific Office, Austrian Agency for Health and Food Safety
• Joan O’Callaghan, Research Scientist for Regulatory Science Ireland, Health Products Regulatory Authority, Ireland
The full speaker line-up and detailed agenda are available online at http://www.biosimilars-europe.com/pr1
Now in its 7th year, the well-established conference series has received positive feedback from the industry such as:
"Really wide range of topics" - Kantar Health
"Rich in information and quality speakers" - Globyz Pharma
"Great discussions, networking and education" - Apobiologix
"Interesting mix of scientists, legal and commercial folk" – Allergan
"Impressive - beat my expectations" – Teva
Registration is now open at www.biosimilars-europe.com
Biosimilars Europe 2016
Conference: 29th & 30th Sept 2016 | Interactive Workshops: 28th Sept 2016
Holiday Inn Kensington Forum, London UK
www.biosimilars-europe.com
Proudly Sponsored by: Abzena
*Source: http://bit.ly/1Z5zmm0
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Widely recognized as one of the most profitable areas of drug development, the global biosimilars market is expected to grow at a CAGR of 40.3% by 2020.* With a raising demand for cost effective biosimilar drugs, Biosimilars Europe 2016 returns for its 7th annual show to showcase the latest updates in regulation, patent expiries and tactical approaches to market entry through informed guidance delivered by a top panel of speakers such as Merck Group, Boehringer Ingelheim GmbH, Bristows LLC and medical agencies from across Europe.
Agenda Highlights Include:
* Insight into future projections presented in an opening keynote by industry specialist, Dr Duncan Emerton, FirstWord.
* 1st hand experience on strategy and portfolio management in a VUCA (Volatile, Uncertain, Complex & Ambiguous) world through a case study on emerging biosimilars, presented by Merck Group.
* Case study updates into both USA and UK litigation with Bristows LLP.
* Guidance into entering emerging markets with insight into current guidelines, regulation, and pricing & reimbursement strategies, from Shanghai CP Guojian Pharmaceuticals.
* A spotlight session on commercialisation featuring talks from RJW & Partners and Abzena.
* A spotlight session on cutting edge technological developments with progressive outlook into bioanalytical analysis, yielding 3D structure of monoclonal antibodies, and opportunities for biosimilars in medical device components.
The Notable Speaker Line-Up Will Include:
• Huiguo Hu, General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co Ltd
• Dr Niraj Chhaya, Risk Management, Boehringer Ingelheim GmbH
• Atanas Dimitrov, Head of Strategy & Portfolio Management, Merck Group
• Dr Alok Sharma, Head, Bio-Analytical Development, Lupin Ltd
• Dr Andrea Laslop, Head of Scientific Office, Austrian Agency for Health and Food Safety
• Joan O’Callaghan, Research Scientist for Regulatory Science Ireland, Health Products Regulatory Authority, Ireland
The full speaker line-up and detailed agenda are available online at http://www.biosimilars-europe.com/pr1
Now in its 7th year, the well-established conference series has received positive feedback from the industry such as:
"Really wide range of topics" - Kantar Health
"Rich in information and quality speakers" - Globyz Pharma
"Great discussions, networking and education" - Apobiologix
"Interesting mix of scientists, legal and commercial folk" – Allergan
"Impressive - beat my expectations" – Teva
Registration is now open at www.biosimilars-europe.com
Biosimilars Europe 2016
Conference: 29th & 30th Sept 2016 | Interactive Workshops: 28th Sept 2016
Holiday Inn Kensington Forum, London UK
www.biosimilars-europe.com
Proudly Sponsored by: Abzena
*Source: http://bit.ly/1Z5zmm0
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Teri Arri
+44 (0) 207 827 6140
http://www.biosimilars-europe.com/pr.com
Teri Arri
+44 (0) 207 827 6140
http://www.biosimilars-europe.com/pr.com
Contact
Categories